Damodaran Targets VC's 'Weakest Link': Growth Over Profits

Aswath Damodaran, the New York University professor known as the "Dean of Valuation," has published a new essay arguing that venture capital's most consequential flaw is the trade-off it forces on startups: scale now, profit later — maybe never.

The piece, titled "The Scaling versus Profitability Trade-off: Venture Capital's Weakest Link!" and published on his Substack, takes aim at a structural feature of the venture model rather than at any single company or fund. Damodaran's core claim is that the industry's economics reward rapid growth in valuation over durable operating economics, and that this incentive runs through the entire chain — from founders to general partners to limited partners.

The timing matters. The essay arrives after a period in which private-market darlings built on subsidized growth have been repriced sharply lower, and in which several high-profile venture-backed companies have stumbled in or near public markets. Damodaran has spent years arguing that the tools of valuation discipline were set aside during the easy-money years, and this essay extends that critique to the mechanics of the asset class itself.

His framing of the problem centers on a choice startups face once they accept venture money. Capital injections can fund explosive user or revenue growth, but the same money creates pressure to defer profitability in pursuit of scale — on the theory that market dominance secured early will convert into margins later. Damodaran's essay treats that theory as venture capital's "weakest link": the assumption that scaling and profitability will eventually reconcile, when in many business models they never do.

The critique is not that growth is bad. Damodaran has long distinguished between companies that grow because unit economics work and companies that grow because capital covers the gap between price and cost. The essay's target is the second category — businesses whose expansion depends on continuing infusions of outside money and whose valuations reflect narrative rather than cash generation.

For the venture industry, the implications are uncomfortable. If the scaling-first playbook systematically overvalues companies that cannot convert revenue to profit, then the returns of the asset class depend on exit timing rather than business quality — a proposition that works in rising markets and fails when liquidity tightens. Limited partners, in this reading, are exposed not just to individual company risk but to a model-wide bias toward growth at any cost.

Damodaran's position carries weight because of his standing in the valuation field. His textbooks and annual valuation datasets are standard references in business schools and analyst desks, and his public critiques — of Tesla bulls and bears alike, of the IPO market, of "story stocks" — have made him one of the most widely read voices on how companies are priced. When he calls something the asset class's weakest link, it is a diagnosis of structure, not a call on any one position.

The essay also speaks directly to founders. The venture path is not the only path, and Damodaran's broader body of work consistently emphasizes that owners who retain control can build profitable, slower-growing businesses that create durable value without dependence on the next funding round. The scaling-versus-profitability trade-off, in his telling, is a choice — and one too many founders make by default rather than by analysis.

For investors and operators watching the private markets, the essay lands amid a live debate over whether the era of growth-at-all-costs has genuinely ended or merely paused. Damodaran's answer is structural: until venture economics stop rewarding scale for its own sake, the trade-off he identifies will keep producing companies that are big, expensive and unprofitable. Readers who want his full argument, data and worked examples can find the essay on his Substack, where he publishes his analyses free of charge.